US FDA Accepts CeleCor’s NDA for Heart Attack Drug Zalunfiban
CeleCor’s Zalunfiban is a subcutaneously injected inhibitor of the platelet glycoprotein (GP) IIb/IIIa receptor designed for rapid pre-hospital treatment of STEMI heart attacks.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
CeleCor’s Zalunfiban is a subcutaneously injected inhibitor of the platelet glycoprotein (GP) IIb/IIIa receptor designed for rapid pre-hospital treatment of STEMI heart attacks.
The Resident Doctors’ Association (RDA), All India Institute of Medical Sciences (AIIMS) Bhopal, has partnered with MedLern to strengthen resuscitation training and emergency preparedness among healthcare professionals through HeartCode Complete, an American Heart Association (AHA) programme. Under the collaboration, healthcare professionals at RDA AIIMS Bhopal will have access to a structured resuscitation training programme designed […]
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.

